INTRODUCTION
In the past few years, several studies have identified a previously uncharacterized prevalence of structural variants of DNA along chromosomes in the size range of 1 kb or greater, adding to the catalog of variants in the human genome (Table 1) . Namely, sub-microscopic (usually less than 3 Mb) copy number variations (CNVs) and inversions have been found to occur in every genome studied at high frequencies when compared with the equivalent classes of cytogenetically detectable rearrangements (1 -8) . Similar findings are also now being made more readily in disease gene studies.
These discoveries have come somewhat later than the description (and generation of comprehensive maps) of single nucleotide polymorphisms (SNPs) (9, 10) , microsatellites (11, 12) and minisatellites (13) , as well as catalogs of cytogenetically detectable heteromorphisms and rearrangements, because of limits of resolution in the technology at that time. However, new developments in genome-wide scanning methodologies using genomic clone and oligonucleotidebased arrays occurring in parallel with the availability of a reference human genome sequence now provide opportunity to generate advanced maps of structural variation in worldwide populations. Moreover, next generation sequencing technologies and computational comparisons of sequences from different sources will yield a vast number of variants primarily in the ,1 kb size range that have not been described previously. Comprehensive reviews describing the discovery # The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org and properties of, in particular, CNVs, but also other structural variants, have been published recently (14 -19) . Here, we highlight the latest findings, with a particular emphasis on the new sub-microscopic variants being increasingly described in the 1 kb to 3 Mb size range and how they may influence phenotype or be involved in disease.
STRUCTURAL VARIATION INFLUENCING PHENOTYPE
Changes in DNA that affect gene function (often through affecting dosage) can have a deleterious effect on the reproductive fitness of an organism, and in some cases represent lethal mutations. In these circumstances, the variants would eventually be destined to disappear, but they can often exist in a heterozygous form for many generations. In between these extremes of selectively neutral variants and lethal mutations lie variants that can influence physiological, biochemical, morphological and pathological variation in the human population. Recent descriptions of numerous 'genesized' (the average size of a gene being 70 kb) submicroscopic structural variants in all genomes have generated significant excitement in the field (20 -25) , because (i) it was presumed they probably should exist for the same reasons as SNPs and microscopic variants; (ii) their sheer size (often affecting hundreds to thousands of nucleotides of DNA) increases the likelihood that the alteration is, in fact, a genomic lesion explaining disease outcomes; (iii) as such, some will also be shown to predispose to disease either directly or in combination with other variants and factors and (iv) some will provide substrate for evolutionary change. The description of all variants will be important for many wide-ranging reasons, better resolving a more completely annotated reference genome sequence to understanding implications in pharmacogenomics and clinical diagnostic testing.
It has been well established in many classic (26 -33) as well as in more recent studies of monogenic disease (34), oligogenetic disease (35 -41) , and most recently in complex disease that the study of such chromosome rearrangements can be the most rapid approach to identify candidate susceptibility loci and genes (that then need to be confirmed in other samples). For complex diseases (note that in some cases, these were the Mendelian sub-forms of complex disease demonstrating the same phenotypic endpoint), examples include: in autism, X-chromosome deletions led to the identification of the neuroligin NLGN3 and NLGN4 genes (42); in schizophrenia, a familial chromosome 1 translocation led to the discovery of the DISC1 and DISC2 genes (43); in dyslexia, distinct chromosomes 3 and 15 translocations led to the discovery of ROBO1 and DYXC1, respectively (44, 45) ; in severe speech and language disorder, a chromosome 7q31 translocation pinpointed the FOXP2 gene (46) ; in Tourette syndrome, a de novo inversion led to SLITRK1 involvement (47); in severe expressive language delay, microduplication of the Williams -Beuren syndrome locus on chromosome 7q11.23 (48) and in early onset Parkinson and Alzheimer's disease, duplications of SNCA and APP on chromosomes 4 and 21, respectively, have been shown to be causative (49, 50) .
Indeed, the primary message of this review is to increase the awareness of the necessity for including steps for screening for structural variants in genetic experiments. This was (125) exquisitely demonstrated in a recent study showing that copy number polymorphism in the FCGR3 gene predisposes to glomerulonephritis in humans and rats (51) . Preliminary data suggest that dozens of CNVs alone will be found in a given genome when assessed using comprehensive scanning methodologies. The sub-microscopic variants will be intermediate in size and frequency in comparison to occurrence of cytogenetically detectable and smaller (,1 kb) polymorphisms. These aberrations can be hundreds of kilobases long, having important implications for the potential effect they may exert on genes and transcriptional regulation ( Fig. 1) . Moreover, a large number of CNVs have been shown to contain one or more entire coding transcripts (1, 2, 52, 53) . In studies where these genes have been characterized, there seems to be a direct , where there is a direct correlation between genotype and phenotype. Copy number polymorphisms where a gene is located entirely within a region that varies in copy number (B) have also been described to show a direct correlation between gene copy number and gene expression. Another mechanism by which CNVs may have an influence on disease phenotype is if the remaining copy harbors a risk allele that becomes apparent only in the hemizygous state (C). The opposite scenario may also occur, with an increased number of copies harboring a risk allele, causing a concurrent increase in disease susceptibility. It can also be hypothesized that CNVs may affect gene expression without directly changing the gene copy number. Gains or losses affecting the regulatory elements or promoter regions can also be important contributors to differences in gene expression. This could involve either loss of an element of transcriptional regulation (D and F) or a loss/gain changing the structural properties of DNA inhibiting enhancer interaction, chromatin structure or access of transcription factors to their binding sites (E). Interaction and additive models with any of these scenarios combined or in combination with any type of variation at other loci can be expected to be the cause of more complex genetic traits.
correlation between increases in gene copy number and increased levels of mRNA (53) (54) (55) (56) . Polymorphic deletions containing entire genes have also been described, where a fraction of the population are homozygous for the deletion allele and, therefore, do not have the gene present in their genome (6, 8, 57) . Most of the genes in this category belong to gene families or are recently duplicated in evolutionary history, and this may increase the tolerance for null alleles. Specific categories of genes seem over-represented in CNVs including those important for interaction with the surrounding environment, such as olfaction and response to external stimuli (19, 58) . Examples of such polymorphic genes include glutathione S-transferase genes (59,60), cytochrome P450 genes (61 -65) and the complement component C4 (66) . In each case, changes to gene copy number have been shown to give rise to concomitant changes in the level of enzyme activity, with phenotypic consequences. Another example is the CCL3L1 gene, where the increased copy number has been shown to be protective against HIV infection (56) .
Inversions represent another class of structural variation (Table 1) , but knowledge of their prevalence in the human genome is more limited. This is partly due to a lack of technologies for robust and inexpensive discovery of such balanced rearrangements. In addition, preliminary data indicate that inversion variants are less abundant than CNVs in the human genome (4). However, there are a number of welldocumented cases where inversion variants can be associated with disease predisposition, primarily in microdeletion syndromes. In these instances, the inversion variant need not be a direct cause of the disease, but instead it can act as a risk factor for microdeletion to occur in the offspring, as appears to be the case in Williams -Beuren (67), Angelman (68) and Sotos syndromes (69) .
POTENTIAL LONG-RANGE (POSITION) EFFECTS OF STRUCTURAL VARIANTS ON GENES
As discussed, structural variants can affect dosage by directly interrupting genes, but it is important to appreciate that they can have an equivalent effect at a distance (in an indirect manner) (Fig. 1) . Although genes only represent a small portion (,3%) of the human genome and there are hundreds of putative 'gene deserts', sometimes millions of base pairs in size (70 -72) , there is now substantial evidence that regulatory elements of genes can reside up to a million base pairs or more away ( Fig. 1; Table 2 ) (Supplementary Material, Table S1 ). Thus, structural variants cannot be presumed to be selectively neutral because they encompass only noncoding segments, but instead a careful assessment of nearby genes that may be affected via a 'position effect' mechanism also needs to be considered.
Position effect refers to the alteration of a gene's expression pattern as a result of a change in its genomic location or chromatin environment. This phenomenon has been most extensively studied in Drosophila (73) and yeast (74) , but an increasing number of examples in humans have been reported, including a variety of developmental disorders such as aniridia (75 -78) , holoprosencephaly (79 -81) , campomelic dysplasia (82 -90) , thalassemias (91 -94) , X -Y sex reversal (95, 96) and others (Supplementary Material, Table S1 ). Position effects can be caused by a variety of mechanisms. These (97) . In recent reviews (80, 97) , several additional examples of congenital abnormalities resulting in either obvious or postulated position effects in humans have been reported. Here, we call attention to some studies from the past few years, highlighting how the structural variants can be involved in disease through different mechanisms of action (Table 2 ) (additional historical studies are summarized in Supplementary Material, Table S1 ). In most cases, the effect of genomic rearrangement on gene expression has been inferred, rather than observed directly. This is often due to the unavailability of appropriate tissue or developmental timing of expression that would render gene expression analysis impossible. As an example, a translocation that disrupts the HDAC9 gene at 7p21.1 has its reciprocal breakpoint on chromosome 1, 500 kb from the TGFB2 gene. The patient carrying this translocation has Peter's anomaly, a defect of the anterior chamber of the eye, and as Tgfb2 null mice have very similar developmental eye defects, and therefore, the authors consider a position effect at TGFB2, rather than HDAC9 disruption, to be the most likely underlying pathology (98) . A more complex example is a 23 -25 kb deletion and 340 kb insertion at the deletion point, 67 kb 3 0 to the SOX3 gene, found in a patient with X-linked recessive hypoparathyroidism (99) . It is presumed that down-regulation of SOX3 results in the phenotype, as SOX3 has been observed to be expressed in the developing parathyroid of mouse embryos.
In ) report a patient with a ring (X) chromosome that is presumed to cause a down-regulation of the SHOX gene, resulting in short stature in that patient, although a significant amount of Xp and Xq material is also deleted, including several other genes. Finally, in an extreme case carrying a de novo t(6;7) (p21.1;q36) reciprocal translocation exhibiting both holoprosencephaly and cleidocranial dysplasia, there are two apparent position effect mutations in the same individual: the 7q36 breakpoint mapping 15 kb telomeric to the 5 0 end of Sonic Hedgehog causes holoprosencephaly and the 6p21.1 breakpoint mapping 800 kb upstream of CBFA1 (RUNX2) causes cleidocranial dysplasia (80) .
It is striking that a majority of genes reported to be affected by apparent position effects in humans are involved in developmental syndromes. This could be due to ascertainment bias, as phenotypes in these patients tend to be either atypical or unusually mild. Alternatively, it could be that other classes of genes, e.g. those encoding enzymes, are much more tolerant to positional silencing or down-regulation and that individuals with such rearrangements thus escape clinical notice. It has also been suggested that large 'gene deserts' often found around the developmental genes (71) may serve as enhanced targets for chromosomal rearrangements (105) . Notwithstanding, the take home message from these studies and others is that the structural variant need not only affect what we usually define as the classical gene unit to have an effect; proximal and distal genes also need to be considered.
MEDICAL AND BIOLOGICAL SIGNIFICANCE
With the ability to recognize dozens of sub-microscopic variants in all genomes, a hierarchical paradigm of how to differentiate the manifestation of disease-(or phenotype-) associated changes needs to be considered (Fig. 2) . For example, in some cases, a structural variant correlates directly with the disease, such as the case in dosage-related microdeletions and duplications that cause genomic disorders and in other cases described earlier (106) . Family-based studies can demonstrate whether a change is de novo or has been inherited and, in the latter case, whether there are likely to be associated phenotypic consequences. However, there are numerous examples of lack of penetrance or variable expression of phenotype in inherited chromosomal rearrangements (107) , requiring analysis be extended to a larger population of controls. Other factors such as the genomic context (e.g. types of genes and likelihood to be affected by position effect), the heritable stability of the variant (it could predispose to other mitotic or meiotic rearrangements), influence of other variants and possible parent-of-origin effects (e.g. imprinted regions) all need to be considered when evaluating the effect at the genic level.
Databases cataloging large-scale genotype and phenotype correlations (17, 70, 108) will be increasingly important to help discern how these changes might cause phenotypic or functional outcomes (Table 3 provides (109) and HapMap samples (6, 8) .
CONCLUSIONS AND FUTURE STUDIES
The complexity of variation in the human genome continues to be unraveled, providing opportunity to explain genetic contributions to disease in a more comprehensive manner. Going forward into the next few years, studies examining the role of sub-microscopic structural variation will become a predominant theme because of significant advances in technology allowing for the scanning of genomes at relatively high resolution. In fact, on the basis of the numbers of discoveries and impact alone in the past 2 years, it could be argued that we have entered a 'cytogenomic' era for discovery in human genetics. In large-scale population-based whole genome association studies (Supplementary Material, Table S3 ), and in any disease gene study, a component of assessing structural variation content should be incorporated. However, comprehending the contribution of these variants will require the understanding of wide-ranging data from simple presence or absence (in cases and controls) to the position and context in the genome (Fig. 2 ). It will be important to determine the new mutation rate (25, 110) of these variants across the genome, including the heterochromatic regions.
The next frontier will be to fully catalog all the structural variants in the 1 kb to 3 Mb size range discussed here, but also all other variations in the 1 bp to 1 kb size range (Table 1 ), which will probably be best discerned through personalized genome (re-)sequencing (111) . Coupling all of this information to large cohorts of meticulously phenotyped sample collections and corresponding databases would provide insight toward understanding the etiology of many unresolved diseases.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
